# FDA EIR - Revance Therapeutics, Inc. - July 02, 2021

Source: https://www.globalkeysolutions.net/records/eir/revance-therapeutics-inc/1510d06c-9272-4e0c-a5da-eeffa081a9f1

> FDA EIR for Revance Therapeutics, Inc. on July 02, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Revance Therapeutics, Inc.
- Inspection Date: 2021-07-02
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [CRL - Unknown Date](https://www.globalkeysolutions.net/records/crl/revance-therapeutics-inc/04992544-f520-4579-9861-784ea9ce1560)
- [483 - 2025-02-27](https://www.globalkeysolutions.net/records/483/revance-therapeutics-inc/1e4e8ce1-6bdf-4c1a-9d3f-7df594b9a26a)

## Related Officers

- [Joao Pedras-Vasconcelos](https://www.globalkeysolutions.net/people/joao-pedras-vasconcelos/143cf25e-168d-43da-adc8-9107c4f01b44)
- [ Investigator, Consumer Safety Officer](https://www.globalkeysolutions.net/people/thuy-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [recipient](https://www.globalkeysolutions.net/people/abhay-joshi/6a6a3ade-e0d6-4d6f-b124-7f114f67de08)
- [Senior Consumer Safety Officer](https://www.globalkeysolutions.net/people/carla-j-lundi/a10ed698-54fe-4635-a766-8c31f501dfb2)

Company: https://www.globalkeysolutions.net/companies/revance-therapeutics-inc/33277fcf-5886-406e-8332-bc85057ba4bc

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c